Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Targeting indolent non-Hodgkin lymphoma.
Journal: Expert review of hematology
Published: March 10, 2017
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.
Journal: American journal of hematology
Published: February 12, 2015
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Journal: British journal of haematology
Published: January 06, 2014
Showing 1-3 of 3
Last Updated: 09/26/2026